[HTML][HTML] EGFR in cancer: Signaling mechanisms, drugs, and acquired resistance
ML Uribe, I Marrocco, Y Yarden - Cancers, 2021 - mdpi.com
Simple Summary Growth factors are hormone-like molecules able to promote division and
migration of normal cells, but cancer captured the underlying mechanisms to unleash tumor …
migration of normal cells, but cancer captured the underlying mechanisms to unleash tumor …
[HTML][HTML] The role of SOX family members in solid tumours and metastasis
Cancer is a heavy burden for humans across the world with high morbidity and mortality.
Transcription factors including sex determining region Y (SRY)-related high-mobility group …
Transcription factors including sex determining region Y (SRY)-related high-mobility group …
[HTML][HTML] Non-canonical hedgehog signaling pathway in cancer: activation of GLI transcription factors beyond smoothened
S Pietrobono, S Gagliardi, B Stecca - Frontiers in genetics, 2019 - frontiersin.org
The Hedgehog-GLI (HH-GLI) pathway is a highly conserved signaling that plays a critical
role in controlling cell specification, cell–cell interaction and tissue patterning during …
role in controlling cell specification, cell–cell interaction and tissue patterning during …
[HTML][HTML] Hedgehog signaling and truncated GLI1 in cancer
D Doheny, SG Manore, GL Wong, HW Lo - Cells, 2020 - mdpi.com
The hedgehog (HH) signaling pathway regulates normal cell growth and differentiation. As a
consequence of improper control, aberrant HH signaling results in tumorigenesis and …
consequence of improper control, aberrant HH signaling results in tumorigenesis and …
[HTML][HTML] STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway
J Pencik, C Philippe, M Schlederer, E Atas… - Molecular Cancer, 2023 - Springer
Prostate cancer (PCa) is a common and fatal type of cancer in men. Metastatic PCa (mPCa)
is a major factor contributing to its lethality, although the mechanisms remain poorly …
is a major factor contributing to its lethality, although the mechanisms remain poorly …
[HTML][HTML] SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells
M Herreros-Villanueva, JS Zhang, A Koenig, EV Abel… - Oncogenesis, 2013 - nature.com
SOX2 (Sex-determining region Y (SRY)-Box2) has important functions during embryonic
development and is involved in cancer stem cell (CSC) maintenance, in which it impairs cell …
development and is involved in cancer stem cell (CSC) maintenance, in which it impairs cell …
Genetics and biomarkers in personalisation of lung cancer treatment
R Rosell, TG Bivona, N Karachaliou - The Lancet, 2013 - thelancet.com
Non-small-cell lung cancer is often diagnosed at the metastatic stage, with median survival
of just 1 year. The identification of driver mutations in the epidermal growth factor receptor …
of just 1 year. The identification of driver mutations in the epidermal growth factor receptor …
[HTML][HTML] SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells
R Santini, S Pietrobono, S Pandolfi, V Montagnani… - Oncogene, 2014 - nature.com
Melanoma is one of the most aggressive types of human cancer, characterized by enhanced
heterogeneity and resistance to conventional therapy at advanced stages. We and others …
heterogeneity and resistance to conventional therapy at advanced stages. We and others …
Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy
RL Sleightholm, BK Neilsen, J Li, MM Steele… - Pharmacology & …, 2017 - Elsevier
Chemokine networks regulate a variety of cellular, physiological, and immune processes.
These normal functions can become appropriated by cancer cells to facilitate a more …
These normal functions can become appropriated by cancer cells to facilitate a more …
[HTML][HTML] Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma
Basal cell carcinomas (BCCs) and a subset of medulloblastomas are characterized by loss-
of-function mutations in the tumor suppressor gene, PTCH1. PTCH1 normally functions by …
of-function mutations in the tumor suppressor gene, PTCH1. PTCH1 normally functions by …